Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its boronic acid group enables Suzuki-Miyaura cross-coupling reactions, allowing efficient construction of biaryl structures in drug molecules. Also employed in the preparation of protease inhibitors due to its ability to mimic transition states in peptide bond hydrolysis. Commonly utilized in medicinal chemistry for lead optimization in drug discovery programs targeting inflammatory and oncological diseases.